Skip to main content
. 2025 May 7;55(6):1429–1448. doi: 10.1007/s40279-025-02202-9

Table 1.

PECOS (participants, exposure, comparator, outcomes, study design) approach

PECOS element Details
Participants Elite and sub-elite athletes, non-athletes and healthy subjects
Exposure AMPD1 C34T polymorphism genotyping
Comparators Athletes (endurance and power sports athletes) versus controls (non-athletes)
Outcomes Genotypic and allelic frequencies of AMPD1 C34T polymorphism
Study design Cross sections, case-controls, cohorts and all interventional studies